MSB 3.16% $1.31 mesoblast limited

Market opportunity aGVHD, page-42

  1. 3,902 Posts.
    lightbulb Created with Sketch. 1325
    To fund every single trial for every application is impossible.

    And the fix is, more partners or licensees as the case may be. I'm wondering about off label applications too, not just label extension, where will that lead to.

    Still good for MSB I'm sure, the IP cover has got to be broad with over 800 patents, covering technology as well as method/usage.
    Last edited by Treed: 26/07/18
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.